Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 TrevenaAptinyxArbutus BiopharmaImprimis PharmaceuticalsAvadel Pharmaceuticals
SymbolNASDAQ:TRVNNASDAQ:APTXNASDAQ:ABUSN/ANASDAQ:AVDL
Price Information
Current Price$1.05$3.81$2.34N/A$2.19
52 Week RangeBuyBuyHoldBuyHold
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyHold
Consensus Price Target$6.6667$14.40$6.8333$10.75$4.00
% Upside from Price Target534.92% upside277.95% upside192.02% upside∞ upside82.65% upside
Trade Information
Market Cap$96.97 million$125.86 million$136.44 million$106.39 million$83.30 million
Beta2.35N/A1.87-1.061.66
Average Volume2,305,825311,494882,758482,230300,254
Sales & Book Value
Annual Revenue$5.73 million$6.57 million$5.90 million$26.77 million$103.27 million
Price / Sales16.9219.4622.550.000.79
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.50 per share$4.46 per share$1.33 per share$0.13 per share$0.08 per share
Price / Book2.100.851.760.0027.38
Profitability
Net Income$-30,780,000.00$-53,280,000.00$-57,060,000.00$-11,980,000.00$-95,300,000.00
EPS($0.42)($2.64)($1.02)($0.60)($1.99)
Trailing P/E RatioN/A0.00N/AN/A0.00
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-1,166.40%-1,237.92%-16.81%-111.19%
Return on Equity (ROE)-61.47%-37.53%-95.26%-231.16%-215.96%
Return on Assets (ROA)-37.52%-35.89%-33.30%-25.18%-31.99%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.18%N/A0.06%2.84%41.63%
Current Ratio3.58%23.43%12.75%1.13%3.27%
Quick Ratio3.58%23.43%12.75%0.88%3.13%
Ownership Information
Institutional Ownership Percentage23.58%58.37%41.76%16.11%52.80%
Insider Ownership Percentage3.40%8.47%9.60%13.78%15.23%
Miscellaneous
Employees29N/A79N/A144
Shares Outstanding92.35 million33.56 million56.85 million23.28 million37.35 million
Next Earnings Date8/1/2019 (Estimated)8/13/2019 (Estimated)8/1/2019 (Estimated)N/A8/6/2019 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable
 TrevenaAptinyxArbutus BiopharmaImprimis PharmaceuticalsAvadel Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel